Amino acids in neurobiology: Neuroprotective and neurotoxic aspects of amino acids involved in neurotransmission and neuromodulation – General Introduction B. D. KretschmerW. J. SchmidtM. Herrera-Marschitz Special Issue: Amino Acids in Neurobiology Pages: 1 - 7
Co-activation of the phosphatidylinositol-3-kinase/Akt signaling pathway by N-methyl-D-aspartate and TrkB receptors in cerebellar granule cell neurons D. ZhuR. H. LipskyA. M. Marini Pages: 11 - 17
Inhibition of phosphatidylcholine synthesis is associated with excitotoxic cell death in cerebellar granule cell cultures T. GasullN. DeGregorio-RocasolanoR. Trullas Pages: 19 - 25
Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity M. T. Fernández-SánchezR. Díaz-TrellesA. Novelli Pages: 31 - 36
Comparison of the in vitro and in vivo neurotoxicity of three new sources of kainic acid R. A. R. TaskerP. B. BernardA. Novelli Pages: 45 - 54
Novel roles of amino acids and analogues in neurodegenerative disorders – Introduction R. M. KostrzewaJ. P. KostrzewaR. Brus Chapter II Pages: 55 - 56
Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease R. M. KostrzewaJ. P. KostrzewaR. Brus Pages: 57 - 63
L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent O. Hornykiewicz Pages: 65 - 70
Restorative effects of glutamate antagonists in experimental parkinsonism T. ArcherT. PalomoA. Fredriksson Pages: 71 - 85
Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key? L. C. WalkerF. BianH. LeVine Pages: 87 - 93
Submolecular adventures of brain tyrosine: what are we searching for now? A. KochmanCz. KośkaD. Metodiewa Pages: 95 - 101
Mechanisms and treatment of L-DOPA-induced dyskinesias – Introduction W. Danysz Chapter III Pages: 103 - 103
Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease M. A. Cenci Pages: 105 - 109
Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptics drug and postnatal administration A. FredrikssonT. Archer Pages: 111 - 132
Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease J. D. OhT. N. Chase Pages: 133 - 139
Recognition and treatment of response fluctuations in Parkinson's disease: Review article L. Verhagen Metman Pages: 141 - 145
Glutamatergic mechanisms in different disease states: overview and therapeutical implications – An introduction T. M. Tzschentke Chapter IV Pages: 147 - 152
Modulation of glutamate receptors: Strategies for the development of novel antidepressants P. Skolnick Pages: 153 - 159
Cystine/glutamate exchange serves as the source for extracellular glutamate: Modifications by repeated cocaine administration D. A. BakerH. ShenP. W. Kalivas Pages: 161 - 162
The effects of NMDA receptor antagonists on acute morphine antinociception in mice E. KozelaP. Popik Pages: 163 - 168
Novel approaches to targeting glutamate receptors for the treatment of chronic pain: Review article B. A. Chizh Pages: 169 - 176
Formalin-induced changes of NMDA receptor subunit expression in the spinal cord of the rat C. GaunitzA. SchüttlerC. Allgaier Pages: 177 - 182
Neuro- and psychotropic effects of drugs active at metabotropic glutamate receptors – Therapeutic perspectives – Introduction S. WolfarthK. Ossowska Chapter V Pages: 183 - 184
Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia M. J. MarinoH. AwadP. J. Conn Pages: 185 - 191
The role of striatal metabotropic glutamate receptors in Parkinson's disease K. OssowskaJ. KoniecznyA. Pilc Pages: 193 - 198
The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: Review article K. GołembiowskaJ. KoniecznyS. Wolfarth Pages: 199 - 205
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: Review article R. KuhnA. PaganoF. Gasparini Pages: 207 - 211
Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats J. M. WieronskaB. SzewczykA. Pilc Pages: 213 - 216
Neurobiology of the CNS injury and repair: New roles of amino acids, growth factors and neuropeptides – Introduction H. S. Sharma Chapter VI Pages: 217 - 219
Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage M. BalestrinoM. LensmanA. Cupello Pages: 221 - 229
Repeated topical application of growth hormone attenuates blood-spinal cord barrier permeability and edema formation following spinal cord injury F. NybergH. S. Sharma Pages: 231 - 239
Role of VEGF in an experimental model of cortical micronecrosis J. V. LafuenteS. BulnesH. H. Riese Pages: 241 - 245
Nitric oxide synthase inhibitors in?uence dynorphin A (1–17) immunoreactivity in the rat brain following hyperthermia H. S. SharmaP. Alm Pages: 247 - 259
A new antioxidant compound H-290/51 modulates glutamate and GABA immunoreactivity in the rat spinal cord following trauma H. S. SharmaP.-O. Sjöquist Pages: 261 - 272
Topical application of dynorphin A (1–17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury T. WinklerH. S. SharmaJ. Westman Pages: 273 - 281
Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety A. M. Hernandez-GómezR. Aguilar-RobleroM. Pérez de la Mora Pages: 283 - 290
Molecular imaging of ischemia and angiogenesis – Introduction O. Golubnitschaja Chapter VII Pages: 291 - 291
Molecular imaging of perfusion disturbances in glaucoma O. GolubnitschajaK. WunderlichJ. Flammer Pages: 293 - 299
Targeting of MPEG-protected polyamino acid carrier to human E-selectin in vitro H. W. KangR. WeisslederA. Bogdanov, Jr. Pages: 301 - 308
Perfusion and molecular diffusion-weighted MR imaging of the brain: In vivo assessment of tissue alteration in cerebral ischemia S. FlackeH. UrbachH. H. Schild Pages: 309 - 316
In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration W. BlockF. TräberH. Schild Pages: 317 - 323
Effects of cytoskeletal modi?cations on Ca2+ in?ux after cerebral ischemia K. B. FinkM. PaehrM. Endres Pages: 325 - 329
Early molecular events in the development of the diabetic cardiomyopathy H. MönkemannA. S. De VrieseO. Golubnitschaja Pages: 331 - 336
Effects of dietary de?ciency of selective amino acids on the function of the cornea and lens in rats A. WegenerO. GolubnitschajaG. F. J. M Vrensen Pages: 337 - 342